Other News To Note
Friday, February 25, 2011
Biovest International Inc., of Tampa, Fla., received a loan package of $1.5 million to establish a manufacturing site in Coon Rapids, Minn., for BiovaxID, its personalized cancer vaccine aimed at treating non-Hodgkin's lymphoma. The loan is being provided by the state of Minnesota, the city of Coon Rapids and real estate developer JMS Holdings LLC and is earmarked to support the initial expansion of Biovest's existing 35,000 square foot manufacturing facility to accommodate production for the cancer vaccine.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.